Detalhe da pesquisa
1.
National expert consensus on home-administered oncologic therapies in Spain.
Front Oncol
; 14: 1335344, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38434688
2.
Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis.
Breast Cancer Res
; 15(6): R105, 2013 Nov 06.
Artigo
Inglês
| MEDLINE | ID: mdl-24192331
3.
Observational study of HR+/HER2- metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS).
Clin Transl Oncol
; 25(10): 2950-2959, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37029241
4.
The role of immunotherapy in non-clear cell renal cell carcinoma.
Front Oncol
; 13: 941835, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36816976
5.
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication.
Ther Adv Med Oncol
; 11: 1758835919833867, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31205497
6.
Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials.
Cancer Treat Rev
; 33(5): 474-83, 2007 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-17561350
7.
The use of taxanes in the neoadjuvant treatment of breast cancer: a review of randomized phase II/III trials.
Clin Breast Cancer
; 7(10): 764-74, 2007 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-18021477
8.
Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/ cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer: a randomized phase II trial.
Clin Breast Cancer
; 7(7): 555-8, 2007 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-17509164
9.
Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective study.
PLoS One
; 12(10): e0184181, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28985233
10.
Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile.
Curr Cancer Drug Targets
; 16(5): 415-28, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26278712
11.
Treatment innovations for metastatic breast cancer: nanoparticle albumin-bound (NAB) technology targeted to tumors.
Crit Rev Oncol Hematol
; 89(1): 62-72, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24071503
12.
Genomic profile of breast cancer: cost-effectiveness analysis from the Spanish National Healthcare System perspective.
Expert Rev Pharmacoecon Outcomes Res
; 14(6): 889-99, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25213317
13.
Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study).
Bone
; 68: 32-40, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25108081
14.
Cost-utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain.
Expert Rev Pharmacoecon Outcomes Res
; 13(3): 381-91, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23534988
15.
PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
BMC Med Genomics
; 5: 44, 2012 Oct 04.
Artigo
Inglês
| MEDLINE | ID: mdl-23035882
16.
Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain.
Clin Transl Oncol
; 12(10): 692-700, 2010 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-20947484
17.
Current perspectives of treatment of ductal carcinoma in situ.
Cancer Treat Rev
; 36(7): 507-17, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-20462701
18.
In response: Genomic profile of breast cancer.
Expert Rev Pharmacoecon Outcomes Res
; 15(3): 395-7, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25797142
19.
Supportive care for patients with early breast cancer.
Clin Transl Oncol
; 12(1): 32-42, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-20080469
20.
Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.
Cancer Treat Rev
; 34(8): 701-9, 2008 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-18922644